EPE Special Opportunities NAV Falls 8% in H1 2025, Announces LSA International Acquisition

EPE Special Opportunities' NAV fell 8% in H1 2025 but acquired LSA International, with shares trading at a 50% discount to NAV.

9 September 2025by Joshua Thompson5 min read77 views

This article covers information on EPE Special Opportunities Limited.

LON:ESOZ

EPE Special Opportunities’ half-year: NAV down 8%, new homewares deal on board

EPE Special Opportunities (ESO) has released its interim results for the six months to 31 July 2025. It was a mixed period: the net asset value (NAV – the per-share value of the portfolio) fell, but the Company kept buying back shares, rebuilt liquidity after the period end, and completed a new acquisition that plugs neatly into its existing homewares platform.

Headline numbers investors need to know

Metric	31 Jul 2025	Comparison
NAV per share	301p	Down 8% vs 328p at 31 Jan 2025
Share price	150p	Up 1% vs 149p at 31 Jan 2025
Discount to NAV	50%	55% at 31 Jan 2025
Group cash	£7.0 million	At 31 Jul 2025; £16.1 million at 31 Aug 2025
Buybacks	1.4 million shares	Average price 147p (Apr-Jul 2025)
Unquoted valuation multiple	7.9x EV/EBITDA	Portfolio leverage 1.1x EBITDA
ULNs	£4.0 million	Maturity extended to Jul 2026; interest 8.5% after 23 Jul 2025
ZDP shares	9.5 million in issue	Maturity Dec 2026; carrying value £11.35 million
Profit/(loss)	£(9.06) million	Driven by £7.38 million fair value decrease

Note: liquidity includes cash held by subsidiaries that are wholly owned by ESO.

Why NAV fell and what moved the dial

NAV per share declined to 301p, an 8% drop over the half. The accounts show a £7.38 million negative fair value movement on investments, which more than offset modest income. ESO does not split this movement by asset in the RNS, so we do not have a line-by-line attribution. Management flags a volatile macro backdrop and equity market valuations as ongoing headwinds to fair value marks.

There was no hit from the administration of David Phillips in July, as the investment was already held at a low value. Elsewhere, the unquoted book is valued off an average 7.9x EV/EBITDA multiple (enterprise value to earnings before interest, tax, depreciation and amortisation), with an aggregate net debt level of 1.1x EBITDA across the portfolio – conservative by private equity standards.

Fresh deal: LSA International to sit alongside Rayware

In July, ESO bought a majority stake in LSA International, the premium glassware and interiors brand. Consideration was up to £2.1 million in cash plus 298,013 ESO shares issued to the sellers. The strategy is to combine LSA with Rayware, ESO’s existing homewares platform, to accelerate growth and unlock supply chain and channel benefits.

Share𝕏 in

Investing
Polar Capital Technology Trust Reports 102% NAV Growth in Stellar Fiscal Year
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Investing

Tagged

Last updated

5 July 2026

Star Rating

No ratings yet

Why it matters: this is bolt-on M&A that plays to ESO’s strengths. LSA brings design-led credentials, relationships with premium retailers and hospitality groups, and a strong international footprint. Integrating with Rayware should help scale distribution and procurement. Execution risk exists – integrations always do – but the strategic logic is clear and the entry price, based on disclosed consideration, looks measured.

Portfolio check-in: tangible progress despite choppy markets

Luceco: H1 sales of £125 million, up 15% year-on-year, with adjusted operating profit of £13.5 – 13.8 million. Net debt at 1.6x LTM EBITDA sits within a 1-2x target. Integration of CMD continues to progress.
Whittard: like-for-like sales up 12% year-to-date and retail footfall up 25%. Loyalty programme exceeds 500,000 members. International expansion continues, including premium supermarket launches in China. On 26 August 2025, Whittard refinanced with a £10 million term loan and £2 million revolving credit facility (RCF). Proceeds were returned to ESO, boosting liquidity after the period end.
Rayware: still a tough trading environment, but year-on-year sales growth delivered, with encouraging traction in the US and Amazon channels. Several senior hires were made to support execution.
Pharmacy2U: steady organic growth continues. LloydsDirect integration is adding scale.
Denzel’s: strategy refocused on core national retailers and efficient digital sales. ESO invested £0.4 million in March to support growth and appointed a new COO.

Overall, the portfolio mix remains weighted to branded consumer and healthcare-tech exposure, with one quoted holding (Luceco) and a number of private assets. The concentration is deliberate, but it does mean single-asset movements can swing NAV.

Balance sheet, liquidity and capital management

Liquidity was £7.0 million at 31 July 2025, rising to £16.1 million by 31 August after the Whittard refinance. During the half, ESO extended the maturity of £4.0 million unsecured loan notes (ULNs) to July 2026 and lifted the coupon to 8.5% after 23 July 2025. Zero Dividend Preference (ZDP) shares – a form of non-income paying debt with a fixed redemption value – total 9.5 million in issue and mature in December 2026. Apart from the ULNs and ZDPs, ESO has no other third-party debt at the parent level.

Share buybacks continued: 1.4 million ordinary shares were repurchased in the market between April and July at an average 147p. With the share price at 150p versus a 301p NAV, buybacks at a 50% discount are an accretive use of cash, provided liquidity remains comfortable and portfolio needs are covered.

My take: the good, the bad, and the watch-outs

Positives

50% discount to NAV leaves clear upside if valuations stabilise and realisations land in line with carrying values.
Post-period cash build to £16.1 million gives optionality for support and selective deals.
LSA acquisition looks strategically neat alongside Rayware; scope for synergies and channel expansion.
Portfolio leverage at 1.1x EBITDA is low, which helps in uncertain markets.
Buybacks at a deep discount are sensible and shareholder-friendly.

Negatives

8% NAV drop driven by fair value cuts underlines the sensitivity of unquoted marks to macro and sentiment. ESO has not disclosed asset-level attribution.
Consumer exposure remains meaningful. While Whittard and Rayware are executing, they are not immune to demand swings.
ULN and ZDP maturities cluster in 2026. Asset cover looks fine today, but refinancing or realisations will need careful choreography.

What to watch next

Trading through the key Q4 retail period for Whittard and Rayware, plus early signs of LSA integration benefits.
Luceco’s next update – continued deleveraging and demand trends will influence ESO’s NAV via the listed stake.
Further buybacks while the discount sits around 50% and cash is healthy.
Any new investments or bolt-ons that add diversification without stretching liquidity.

Bottom line

This is a classic private equity investment company update in a difficult market: valuations edged down, operations kept moving forward, and capital discipline tightened. The 50% discount is the headline. If ESO continues to tidy the balance sheet, integrate LSA into Rayware, and demonstrate resilient trading across the portfolio, the gap to NAV should narrow. For now, the shares remain a high-beta way to play a recovery in UK mid-market private equity valuations – with buybacks and improved liquidity providing support while we wait.